Related Experiment Video
Updated: Mar 24, 2026

06:51
Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases
Published on: December 9, 2022
5.5K
Slit-miR-218-Robo axis regulates retinal neovascularization
Yichun Kong1, Bei Sun2, Quanhong Han1
1Tianjin Eye Hospital, Heping, Tianjin 300020, P.R. China.
International Journal of Molecular Medicine
|March 4, 2016
Summary
MicroRNA-218 (miR-218) inhibits retinal angiogenesis by targeting Robo1. Downregulation of miR-218 and its host gene Slit2 in oxygen-induced retinopathy suggests miR-218 as a potential therapeutic target for preventing neovascularization.
Area of Science:
- Ophthalmology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) regulate gene expression and are implicated in various biological processes, including tumor angiogenesis.
- Retinal neovascularization (RNV) is a pathological process contributing to vision loss in diseases like retinopathy of prematurity and diabetic retinopathy.
Purpose of the Study:
- To investigate the role of miR-218 and its host genes, Slit2 and Slit3, in oxygen-induced retinal neovascularization (OIR).
- To elucidate the underlying mechanisms by which miR-218 affects RNV, focusing on its interaction with Robo1.
Main Methods:
- Establishment of a mouse model of oxygen-induced retinopathy (OIR).
- Quantification of miR-218, miR-218-1, miR-218-2, Slit2, and Slit3 expression using RT-qPCR.
- Assessment of RNV via fluorescein angiography and H&E staining.
- Evaluation of Roundabout, axon guidance receptor, homolog 1 (Robo1) expression by western blot.
- Analysis of cell migration using a scratch wound assay.
Main Results:
- miR-218 expression was significantly downregulated in mice with OIR.
- miR-218 directly suppressed Robo1 expression.
- Slit2, the host gene for miR-218-1, was also downregulated in OIR.
- Restoration of miR-218 inhibited retinal angiogenesis by targeting Robo1.
Conclusions:
- The Slit2-miR-218-Robo1 axis plays a crucial role in inhibiting retinal angiogenesis.
- miR-218 demonstrates potential as a novel therapeutic target for preventing pathological RNV.

